Biocept (BIOC) Reports Q4 Loss of $0.87/Share

Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.87), versus ($13.57) reported last year. Revenue for the quarter came in at $76 thousand, versus $19 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• First Industrial Realty (FR) Tops Q1 EPS by 21c
• Wintrust Financial (WTFC) Tops Q1 EPS by 49c
• Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24